RecruitingNCT03647098

Survival Outcomes of Lung Cancer

Survival Outcomes for Lung Cancer


Sponsor

Hunan Province Tumor Hospital

Enrollment

20,000 participants

Start Date

Aug 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting information about survival outcomes for patients with lung cancer who are receiving treatment, to better understand which factors and treatments lead to better results. **You may be eligible if...** - You are 18 years old or older - You have been diagnosed with lung cancer confirmed by a biopsy or lab test - You are in reasonably good physical condition (able to care for yourself and do light activity) - Your expected survival is at least 12 weeks - You have measurable cancer visible on imaging scans - You have adequate blood counts and organ function - You understand the study and are able to give informed consent **You may NOT be eligible if...** - You are unable to understand or agree to participate in the study - You have very poor overall health - You have had certain prior treatments that disqualify you per study criteria - Your organ function (blood, liver, kidneys) is not adequate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTreatment

Treatment decisions guided by molecular profiling and clinical judgment of principal investigators


Locations(1)

Hunan Cancer Hospital

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03647098


Related Trials